{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:25:45Z","timestamp":1725063945332},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"DOI":"10.7759\/cureus.68198","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T12:32:49Z","timestamp":1725021169000},"source":"Crossref","is-referenced-by-count":0,"title":["Akira Endo: Father of Statins"],"prefix":"10.7759","author":[{"given":"Michael D","family":"Cheshire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman  A","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S254016","article-title":"Reflections on atherosclerosis: Lesson from the past and future research directions","volume":"13","author":"Minelli S","year":"2020","unstructured":"Minelli S, Minelli P, Montinari MR. Reflections on atherosclerosis: Lesson from the past and future research directions. J Multidiscip Healthc. 2020, 13:621-33. 10.2147\/JMDH.S254016","journal-title":"J Multidiscip Healthc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: from plaques to genes to statins","volume":"161","author":"Goldstein JL","year":"2015","unstructured":"Goldstein JL, Brown MS. A century of cholesterol and coronaries: from plaques to genes to statins. Cell. 2015, 161:161-72. 10.1016\/j.cell.2015.01.036","journal-title":"Cell"},{"key":"ref3","article-title":"Anichkov and his theory of atherosclerosis","volume":"33","author":"Konstantinov IE","year":"2006","unstructured":"Konstantinov IE, Mejevoi N, Anichkov NM. Anichkov and his theory of atherosclerosis. Tex Heart Inst J. 2006, 33:417-23.","journal-title":"Tex Heart Inst J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114480","article-title":"The diet and 15-year death rate in the seven countries study","volume":"124","author":"Keys A","year":"1986","unstructured":"Keys A, Menotti A, Karvonen MJ, et al.. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 1986, 124:903-15. 10.1093\/oxfordjournals.aje.a114480","journal-title":"Am J Epidemiol"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.41.4S1.I-154","article-title":"Coronary heart disease in seven countries. XVI. The electrocardiogram in prediction of five-year coronary heart disease incidence among men aged forty through fifty-nine","volume":"41","author":"Blackburn H","year":"1970","unstructured":"Blackburn H, Taylor HL, Keys A. Coronary heart disease in seven countries. XVI. The electrocardiogram in prediction of five-year coronary heart disease incidence among men aged forty through fifty-nine. Circulation. 1970, 41:1154-61.","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson PW","year":"1998","unstructured":"Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97:1837-47. 10.1161\/01.cir.97.18.1837","journal-title":"Circulation"},{"key":"ref7","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection","year":"2002","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106:3143-421.","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001, 285:2486-97. 10.1001\/jama.285.19.2486","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"129","author":"Goff DC Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G, et al.. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. Circulation. 2014, 129:S49-73. 10.1161\/01.cir.0000437741.48606.98","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"140","author":"Arnett DK","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, et al.. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019, 140:e596-646. 10.1161\/CIR.0000000000000678","journal-title":"Circulation"},{"key":"ref11","article-title":"Morbidity and Mortality: Chartbook on Cardiovascular, Lung, and Blood Diseases","author":"National Heart","year":"1998","unstructured":"National Heart, Lung, and Blood Institute. Morbidity and Mortality: Chartbook on Cardiovascular, Lung, and Blood Diseases. National Heart, Lung, and Blood Institute, Rockville; 1998."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.191261","article-title":"Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones D","year":"2009","unstructured":"Lloyd-Jones D, Adams R, Carnethon M, et al.. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009, 119:e21-181. 10.1161\/CIRCULATIONAHA.108.191261","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.47.3s1.i-1","article-title":"The coronary drug project. Design, methods, and baseline results","volume":"47","year":"1973","unstructured":"The coronary drug project. Design, methods, and baseline results. Circulation. 1973, 47.I1-50. 10.1161\/01.cir.47.3s1.i-1","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner PL","year":"1986","unstructured":"Canner PL, Berge KG, Wenger NK, et al.. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986, 8:1245-55. 10.1016\/s0735-1097(86)80293-5","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1985.03350290037018","article-title":"Lipid research clinics coronary primary prevention trial results","volume":"253","author":"Virkkunen M","year":"1985","unstructured":"Virkkunen M. Lipid research clinics coronary primary prevention trial results. JAMA. 1985, 253:635-6. 10.1001\/jama.1985.03350290037018","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease","volume":"317","author":"Frick MH","year":"1987","unstructured":"Frick MH, Elo O, Haapa K, et al.. Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987, 317:1237-45. 10.1056\/NEJM198711123172001","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4065\/73.8.764","article-title":"Konrad Bloch - Nobel Prize for research on cholesterol","volume":"73","author":"Shampo MA","year":"1998","unstructured":"Shampo MA, Kyle RA. Konrad Bloch - Nobel Prize for research on cholesterol. Mayo Clin Proc. 1998, 73:764. 10.4065\/73.8.764","journal-title":"Mayo Clin Proc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.70.10.2804","article-title":"Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol","volume":"70","author":"Goldstein JL","year":"1973","unstructured":"Goldstein JL, Brown MS. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc Natl Acad Sci U S A. 1973, 70:2804-8. 10.1073\/pnas.70.10.2804","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","unstructured":"Canada Gairdner International Award. (2024). Accessed. August 21, 2024: https:\/\/www.gairdner.org\/winner\/akira-endo."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.09.008","article-title":"The discovery of statins","volume":"134","author":"Stossel TP","year":"2008","unstructured":"Stossel TP. The discovery of statins. Cell. 2008, 134:903-5. 10.1016\/j.cell.2008.09.008","journal-title":"Cell"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/nm1008-1050","article-title":"A gift from nature: the birth of the statins","volume":"14","author":"Endo A","year":"2008","unstructured":"Endo A. A gift from nature: the birth of the statins. Nat Med. 2008, 14:1050-2. 10.1038\/nm1008-1050","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.86.484","article-title":"A historical perspective on the discovery of statins","volume":"86","author":"Endo A","year":"2010","unstructured":"Endo A. A historical perspective on the discovery of statins. Proc Jpn Acad Ser B Phys Biol Sci. 2010, 86:484-93. 10.2183\/pjab.86.484","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"ref23","unstructured":"National Center for Biotechnology Information. PubChem Pathway Summary for Pathway SMP0121057, Bloch Pathway (Cholesterol Biosynthesis). (2024). Accessed. August 9, 2024: https:\/\/pubchem.ncbi.nlm.nih.gov\/pathway\/PathBank:SMP0121057."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosissup.2004.08.033","article-title":"The origin of the statins","volume":"5","author":"Endo A","year":"2004","unstructured":"Endo A. The origin of the statins. Atheroscler Suppl. 2004, 5:125-30. 10.1016\/j.atherosclerosissup.2004.08.033","journal-title":"Atheroscler Suppl"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)69741-8","article-title":"The absence of sterol synthesis in insects","volume":"234","author":"Clark AJ","year":"1959","unstructured":"Clark AJ, Block K. The absence of sterol synthesis in insects. J Biol Chem. 1959, 234:2578-82.","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1990.tb07420.x","article-title":"Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver","volume":"9","author":"Clarke PR","year":"1990","unstructured":"Clarke PR, Hardie DG. Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. EMBO J. 1990, 9:2439-46. 10.1002\/j.1460-2075.1990.tb07420.x","journal-title":"EMBO J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R600009-JLR200","article-title":"Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy","volume":"47","author":"Steinberg D","year":"2006","unstructured":"Steinberg D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy. J Lipid Res. 2006, 47:1339-51. 10.1194\/jlr.R600009-JLR200","journal-title":"J Lipid Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(80)90124-0","article-title":"Therapeutic effects of ML-236B in primary hypercholesterolemia","volume":"35","author":"Yamamoto A","year":"1980","unstructured":"Yamamoto A, Sudo H, Endo A. Therapeutic effects of ML-236B in primary hypercholesterolemia. Atherosclerosis. 1980, 35:259-66. 10.1016\/0021-9150(80)90124-0","journal-title":"Atherosclerosis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198108273050902","article-title":"Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia","volume":"305","author":"Mabuchi H","year":"1981","unstructured":"Mabuchi H, Haba T, Tatami R, et al.. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia. N Engl J Med. 1981, 305:478-82. 10.1056\/NEJM198108273050902","journal-title":"N Engl J Med"},{"key":"ref30","unstructured":"Akira Endo, contributor to development of statins, dies at 90; his name had been floated for Nobel Prize. (2024). Accessed. August 14, 2024: https:\/\/japannews.yomiuri.co.jp\/society\/obituaries\/20240611-191337\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/289677-akira-endo-father-of-statins","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T12:32:55Z","timestamp":1725021175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/289677-akira-endo-father-of-statins"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.68198","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,30]]}}}